Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification the Cause of Cerebral Infarction in Patients With Cancer

NCT02212496 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02212496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02212496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification the Cause of Cerebral Infarction in Patients With Cancer
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
August 31, 2014
Completion date
March 31, 2018
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

active cancer, cryptogenic embolic stroke